How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
About Agilent Technologies
Agilent Technologies, Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 27,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.1 billion in fiscal year 2005. Information about Agilent is available on the Web at www.Agilent.com.
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent's nanotechnology business and market position following the completion of its acquisition of Molecular Imaging, the growth of Agilent's presence in the nanotechnology area and Agilent's intent not to relocate Molecular Imaging's operations, the ability of Agilent to meet certain strategic objectives, and Agilent's willingness and ability to develop and support Molecular Imaging products following the Closing. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to risks associated with the ability to effectuate the acquisition on a timely basis, risks associated with changes in demand for Agilent's and Molecular Imaging's products and risks associated with the development generally of Agilent's overall strategic objectives.
In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles while it continues to implement cost reductions; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties on our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the period ended January 31, 2005. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news
CONTACT: Agilent Technologies Inc. Janet Smith, 970-679-5397 (Editorial) email@example.com Michele Drake, 650-752-5296 (Editorial) firstname.lastname@example.org Hilliard Terry, 650-752-5329 (Investor) email@example.com KEYWORD: CALIFORNIA ARIZONAINDUSTRY KEYWORD: HARDWARE COMPUTERS/ELECTRONICS MEDICAL PHARMACEUTICAL SOFTWARE MERGERS/ACQSOURCE: Agilent Technologies Inc.
<<Business Wire -- 11/30/05>>